A Randomized, Open-label, Single Dose, Crossover Study to Compare the Pharmacokinetic Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 (1000/10mg) in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2019
Price : $35 *
At a glance
- Drugs Metformin/rosuvastatin (Primary) ; Metformin; Rosuvastatin
- Indications Cardiovascular disorders; Dyslipidaemias; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Jeil Pharmaceutical
- 27 Mar 2019 Status changed from recruiting to completed.
- 14 Nov 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Oct 2018 to 1 Dec 2018.
- 25 Oct 2018 Status changed from not yet recruiting to recruiting.